Your browser doesn't support javascript.
loading
Regulatory effect of isovitexin on MAPK/NF-κB signal in mice with acute ulcerative colitis.
Liu, Ming-Xiu; Li, Ting; Wang, Wei-Guang; Guo, Jing; Wang, Rui-Rui; He, Hong-Ping; Li, Shu-Quan; Li, Yan-Ping.
Afiliação
  • Liu MX; College of Chinese Medicine, Yunnan University of Chinese Medicine, Kunming 650500, China.
  • Li T; College of Chinese Medicine, Yunnan University of Chinese Medicine, Kunming 650500, China.
  • Wang WG; Key Laboratory of Chemistry in Ethnic Medicinal Resources, State Ethnic Affairs Commission and Ministry of Education, Yunnan Minzu University, Kunming 650500, China.
  • Guo J; College of Chinese Medicine, Yunnan University of Chinese Medicine, Kunming 650500, China.
  • Wang RR; College of Chinese Medicine, Yunnan University of Chinese Medicine, Kunming 650500, China.
  • He HP; College of Chinese Medicine, Yunnan University of Chinese Medicine, Kunming 650500, China.
  • Li SQ; College of Chinese Medicine, Yunnan University of Chinese Medicine, Kunming 650500, China.
  • Li YP; College of Chinese Medicine, Yunnan University of Chinese Medicine, Kunming 650500, China.
J Asian Nat Prod Res ; 25(8): 765-782, 2023.
Article em En | MEDLINE | ID: mdl-36394271
The aim of this study was to investigate the anti-inflammatory effects and mechanism of isovitexin on ulcerative colitis mice and RAW264.7 cells. The results showed that isovitexin had strong antioxidant and anti-inflammatory effects, and could restore intestinal barrier integrity (p < 0.01). In addition, isovitexin inhibited the expression of MyD88, TLR4 and NF-κB p65 proteins. At the same time, isovitexin can inhibit the activation of MAPK/NF-κB signaling pathway in RAW264.7 cells. In conclusion, isovitexin has a protective effect on UC mice, and its improvement mechanism of UC might be related to MAPK/NF-κB signaling pathway.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article